Spots Global Cancer Trial Database for liver diseases
Every month we try and update this database with for liver diseases cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Liver Transplantation for Unresectable GIST Liver Metastases | NCT04825470 | Liver Diseases Liver Cancer Liver Metastase... Liver Neoplasms Liver Mass Liver Carcinoma Liver Transplan... Liver Transplan... GIST GIST, Malignant Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Metastases to L... Metastatic Live... Metastasis Metastases Liver Transplan... Transplant Onco... | Liver Transplan... | 18 Years - | Hospital Universitario Virgen de la Arrixaca | |
Quality of Life After Liver Resection | NCT00681499 | Liver Diseases Liver Neoplasms | 18 Years - | University of Bern | ||
Prospective Analysis of In Vivo Laparoscopic Microwave Ablation Thermodynamics | NCT05471596 | Liver Diseases | NeuWave Microwa... | 18 Years - | Wake Forest University Health Sciences | |
Adult-to-Adult Living Donor Transplant Cohort Study | NCT01619475 | Liver Diseases Hepatocellular ... End Stage Liver... Hepatitis C Liver Cirrhosis | 18 Years - | Arbor Research Collaborative for Health | ||
Liver Transplantation for Unresectable GIST Liver Metastases | NCT04825470 | Liver Diseases Liver Cancer Liver Metastase... Liver Neoplasms Liver Mass Liver Carcinoma Liver Transplan... Liver Transplan... GIST GIST, Malignant Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Metastases to L... Metastatic Live... Metastasis Metastases Liver Transplan... Transplant Onco... | Liver Transplan... | 18 Years - | Hospital Universitario Virgen de la Arrixaca | |
Use of N-Acetylcysteine During Liver Procurement | NCT01394497 | Liver Failure Liver Failure, ... Liver Diseases Carcinoma, Hepa... Liver Neoplasms | N-acetylcystein | 18 Years - | Azienda Ospedaliera di Padova | |
Mesenchymal Stem Cells After Renal or Liver Transplantation | NCT01429038 | Liver Failure Kidney Failure | Mesenchymal Ste... | 18 Years - 75 Years | University of Liege | |
Classical Procedure Versus Intrahepatic Glisson's Approach | NCT01567631 | Liver Diseases Liver Neoplasms Hepatic Haemang... | intrahepatic Gl... classical hepat... | 18 Years - 70 Years | Southwest Hospital, China | |
Standardized CEUS Algorithms for Diagnosis of HCC - Prospective German Multicenter Study | NCT03405909 | Hepatocellular ... Cholangiocarcin... Liver Cirrhosis Liver Cancer Liver Neoplasms Liver Diseases | contrast enhanc... MRI Histology | 18 Years - | University Hospital Erlangen | |
Early Detection of Hepatocellular Carcinoma in a High-risk Prospective Cohort (ELEGANCE) | NCT04965259 | Liver Diseases | 40 Years - 90 Years | National Cancer Centre, Singapore | ||
The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma | NCT00827554 | Hepatocellular ... | LMWH TACE | 18 Years - 75 Years | Eastern Hepatobiliary Surgery Hospital | |
Endoscopic Ultrasound Guided Liver Biopsy and Portal Pressure Registry | NCT05817994 | Liver Diseases Liver Neoplasms Liver Dysfuncti... Liver Failure, ... Liver Fibrosis Liver Inflammat... | - | Sheikh Shakhbout Medical City | ||
The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma | NCT00827554 | Hepatocellular ... | LMWH TACE | 18 Years - 75 Years | Eastern Hepatobiliary Surgery Hospital | |
Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC) | NCT01009593 | Hepatocellular ... Hepatocellular ... Carcinoma, Hepa... Liver Diseases Neoplasms by Hi... Digestive Syste... Carcinoma Liver Neoplasms Neoplasms Neoplasms by Si... Digestive Syste... Adenocarcinoma Neoplasms, Glan... | ABT-869 Sorafenib | 18 Years - | Abbott | |
Study of ThermoDox With Standardized Radiofrequency Ablation (RFA) for Treatment of Hepatocellular Carcinoma (HCC) | NCT02112656 | Hepatocellular ... | ThermoDox Dummy infusion | 18 Years - | Imunon | |
Genomic Medicine Risk Assessment Care for Everyone - Implementation Phase | NCT06278883 | Cardiovascular ... Cancer Liver Diseases Hyperthermia | Disease Risk As... | 18 Years - | Duke University | |
Safety and Effectiveness of Eye90 Microspheres™ in the Treatment of Unresectable HCC and mCRC | NCT04926376 | Hepatocellular ... Metastatic Colo... Liver Cancer | Eye90 Microsphe... | 18 Years - 99 Years | ABK Biomedical | |
Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC) | NCT05953337 | Hepatocellular ... Hepatocellular ... Liver Cancer | EYE90 Microsphe... | 18 Years - 99 Years | ABK Biomedical | |
Pharmacokinetics of Paclitaxel in Correlation With Adverse Events in Cancer Patients With and Without Liver Impairment | NCT04863144 | Liver Diseases | Blood samples | 18 Years - 70 Years | Ain Shams University | |
Mesenchymal Stem Cells After Renal or Liver Transplantation | NCT01429038 | Liver Failure Kidney Failure | Mesenchymal Ste... | 18 Years - 75 Years | University of Liege | |
Liver Cancer Prevention Randomized Control Trial | NCT05196867 | Liver Diseases Fibrosis, Liver Cirrhosis, Live... | Intervention Gr... Control Group | 18 Years - | M.D. Anderson Cancer Center | |
Kuopio Ischaemic Heart Disease Risk Factor Study (Nutrition Component) | NCT03221127 | Cardiovascular ... Diabetes Metabolic Syndr... Cancer Inflammatory Di... Atherosclerosis Cognitive Decli... Liver Diseases Death Pain, Chronic Depression Infection Chronic Disease | 42 Years - 73 Years | University of Eastern Finland | ||
A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Hepatic Impairment | NCT02301104 | Advanced Solid ... | TAS-102 | 18 Years - | Taiho Oncology, Inc. | |
Contrast Enhanced Ultrasound Guidance Biopsy for the Diagnosis of Liver Tumors | NCT03811431 | Liver Diseases | Contrast enhanc... | 18 Years - | Iuliu Hatieganu University of Medicine and Pharmacy | |
Utilization of MAsS in Patients Undergoing LT for HCC | NCT05184283 | NAFLD Hepatocellular ... Liver Diseases Liver Cancer Cirrhosis, Live... Hepatitis C | 18 Years - 75 Years | Columbia University | ||
Surefire Infusion System vs. Standard Microcatheter Use During Holmium-166 Radioembolization | NCT02208804 | Colorectal Neop... Neoplasm Metast... Liver Diseases Digestive Syste... | Holmium-166-pol... | 18 Years - | UMC Utrecht | |
Impact of a European Training Program for Robotic Liver Surgery (LIVEROBOT) | NCT05723705 | Liver Diseases Liver Neoplasm Liver Cancer Liver Metastase... Biliary Tract C... Biliary Tract N... Biliary Tract D... | European Multic... | 18 Years - | Amsterdam UMC, location VUmc | |
Prospective Analysis of In Vivo Laparoscopic Microwave Ablation Thermodynamics | NCT05471596 | Liver Diseases | NeuWave Microwa... | 18 Years - | Wake Forest University Health Sciences | |
Pharmacokinetics of Paclitaxel in Correlation With Adverse Events in Cancer Patients With and Without Liver Impairment | NCT04863144 | Liver Diseases | Blood samples | 18 Years - 70 Years | Ain Shams University | |
Surefire Infusion System vs. Standard Microcatheter Use During Holmium-166 Radioembolization | NCT02208804 | Colorectal Neop... Neoplasm Metast... Liver Diseases Digestive Syste... | Holmium-166-pol... | 18 Years - | UMC Utrecht | |
bTAE-HAIC Combined With Lenvatinib and Sintilimab for Infiltrative Hepatocellular Carcinoma | NCT06070636 | Liver Diseases Hepatocellular ... Immunotherapy Lenvatinib Sintilimab | bTAE-HAIC Lenvatinib Sintilimab | 18 Years - 75 Years | Sun Yat-sen University | |
Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC) | NCT01009593 | Hepatocellular ... Hepatocellular ... Carcinoma, Hepa... Liver Diseases Neoplasms by Hi... Digestive Syste... Carcinoma Liver Neoplasms Neoplasms Neoplasms by Si... Digestive Syste... Adenocarcinoma Neoplasms, Glan... | ABT-869 Sorafenib | 18 Years - | Abbott | |
bTAE-HAIC Combined With Lenvatinib and Sintilimab for Infiltrative Hepatocellular Carcinoma | NCT06070636 | Liver Diseases Hepatocellular ... Immunotherapy Lenvatinib Sintilimab | bTAE-HAIC Lenvatinib Sintilimab | 18 Years - 75 Years | Sun Yat-sen University | |
Avatrombopag for Thrombocytopenia in People With Cancer | NCT04437953 | Thrombocytopeni... Cancer Liver Diseases | Avatrombopag | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Surefire Infusion System vs. Standard Microcatheter Use During Holmium-166 Radioembolization | NCT02208804 | Colorectal Neop... Neoplasm Metast... Liver Diseases Digestive Syste... | Holmium-166-pol... | 18 Years - | UMC Utrecht | |
Liver Regeneration | NCT03396705 | Liver Diseases Liver Cancer | Liver Biopsy | 18 Years - | University Health Network, Toronto | |
Adult-to-Adult Living Donor Transplant Cohort Study | NCT01619475 | Liver Diseases Hepatocellular ... End Stage Liver... Hepatitis C Liver Cirrhosis | 18 Years - | Arbor Research Collaborative for Health | ||
Lenvatinib Combined Anti-PD1 Antibody for the Advanced Hepatocellular Carcinoma | NCT04627012 | Hepatocellular ... Anti-PD1 Antibo... Liver Diseases | Lenvatinib Opdivo Camrelizumab Keytruda Toripalimab Sintilimab Tislelizumab | 18 Years - 75 Years | Sun Yat-sen University | |
A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Hepatic Impairment | NCT02301104 | Advanced Solid ... | TAS-102 | 18 Years - | Taiho Oncology, Inc. | |
Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid Tumors | NCT01177007 | Liver Neoplasms | TheraSphere, Yt... | 18 Years - | Yale University | |
A2ALL-Patients Safety System Improvements in Living Donor Liver Transplantation | NCT02073435 | Liver Diseases Hepatocellular ... Endstage Liver ... Liver Cirrhosis | Donor pain mana... | 21 Years - 60 Years | Northwestern University | |
Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy | NCT00526331 | Esophageal Dise... Gastrointestina... Disorder of the... Gynecologic Dis... Kidney Diseases Liver Diseases Pancreatic Dise... Prostate Cancer Spinal Disease | Vigileo Monitor FloTrac Sensor | 18 Years - | M.D. Anderson Cancer Center | |
A Phase II Study of Weekly Genexol-PM in Patients With Hepatocelluar Carcinoma After Failure of Sorafenib | NCT03008512 | Carcinoma, Hepa... | Genexol-PM | 20 Years - | Gachon University Gil Medical Center | |
Spinal Versus Epidural Analgesia in Laparotomic Liver Surgery | NCT02647047 | Secondary Malig... Liver Diseases Liver Neoplasms | Spinal analgesi... Epidural analge... Transversus Abd... Surgical wound ... Acetaminophen Ketorolac Ropivacaine Sufentanil Ropivacaine Ropivacaine | 18 Years - | Ospedale San Raffaele | |
Everolimus in de Novo Liver Transplantation: a Multicentre Randomized Study | NCT01423708 | Liver Failure Liver Diseases Liver Cirrhosis Liver Neoplasms | Everolimus | 18 Years - 70 Years | Azienda Ospedaliera di Padova | |
Liver Cancer Prevention Randomized Control Trial | NCT05196867 | Liver Diseases Fibrosis, Liver Cirrhosis, Live... | Intervention Gr... Control Group | 18 Years - | M.D. Anderson Cancer Center | |
TheraSphere Post-Approval Study to Calculate the Radiation-absorbed Dose of Tc-99m MAA. | NCT05233098 | Hepatocellular ... | Technetium-99m ... | 21 Years - | Boston Scientific Corporation | |
Associating Liver Partition With Portal Vein Ligation for Staged Hepatectomy (ALPPS) vs. Two-Stage Hepatectomy (TSH) for Marginally Resectable Colorectal Liver Metastases (CRLM) | NCT02758977 | Colon Cancer Li... Liver Neoplasms Liver Diseases Secondary Malig... Malignant Neopl... Hepatectomy Surgery | ALPPS TWO STAGE HEPAT... | 18 Years - | University of Zurich | |
TheraSphere Post-Approval Study to Calculate the Radiation-absorbed Dose of Tc-99m MAA. | NCT05233098 | Hepatocellular ... | Technetium-99m ... | 21 Years - | Boston Scientific Corporation | |
Screening of Postoperative Pulmonary Complications by Electrical Impedance Tomography | NCT02337673 | Pulmonary Disea... Postoperative R... Malignant Neopl... Liver Diseases Pancreatic Dise... | 18 Years - | Johannes Gutenberg University Mainz | ||
Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC) | NCT05953337 | Hepatocellular ... Hepatocellular ... Liver Cancer | EYE90 Microsphe... | 18 Years - 99 Years | ABK Biomedical | |
Adult-to-Adult Living Donor Transplant Cohort Study | NCT01619475 | Liver Diseases Hepatocellular ... End Stage Liver... Hepatitis C Liver Cirrhosis | 18 Years - | Arbor Research Collaborative for Health | ||
Breath Analysis Based Disease Biomarkers of COVID-19 and Other Diseases | NCT04341012 | Liver Diseases Liver Cancer COVID19 | Collection of b... | 18 Years - | Mayo Clinic | |
TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC | NCT04518852 | Hepatocellular ... Liver Neoplasms Digestive Syste... Sorafenib Molecular Mecha... Liver Diseases Antineoplastic ... Protein Kinase ... | TACE combined w... | 18 Years - | Sichuan Cancer Hospital and Research Institute | |
Biliary Anastomosis Using Surgical Loupe Versus Microscope in Living Donor Liver Transplantation | NCT04618692 | Liver Failure Liver Diseases Liver Cancer Liver Neoplasms Liver Dysfuncti... | Surgical Loupes Microscope | 18 Years - 75 Years | Istanbul Medipol University Hospital | |
Genomic Medicine Risk Assessment Care for Everyone - Implementation Phase | NCT06278883 | Cardiovascular ... Cancer Liver Diseases Hyperthermia | Disease Risk As... | 18 Years - | Duke University | |
Hepatic and Systemic Hemodynamic Modeling During Liver Surgery | NCT05339984 | Liver Diseases Liver Transplan... | Partial hepatec... liver transplan... Portal vein emb... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
Biliary Anastomosis Using Surgical Loupe Versus Microscope in Living Donor Liver Transplantation | NCT04618692 | Liver Failure Liver Diseases Liver Cancer Liver Neoplasms Liver Dysfuncti... | Surgical Loupes Microscope | 18 Years - 75 Years | Istanbul Medipol University Hospital | |
Trametinib in Combination With Sorafenib in Patients With Advanced Hepatocellular Cancer | NCT02292173 | Hepatocellular ... Liver Cancer | Trametinib Sorafenib | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
S-1/LV One Week on and One Week Off Regimen in Advanced Hepatocellular Carcinoma (HCC) | NCT01533324 | Carcinoma Liver Diseases Hepatocellular ... | S-1 combined wi... | 18 Years - 70 Years | Second Military Medical University | |
Surefire Infusion System vs. Standard Microcatheter Use During Holmium-166 Radioembolization | NCT02208804 | Colorectal Neop... Neoplasm Metast... Liver Diseases Digestive Syste... | Holmium-166-pol... | 18 Years - | UMC Utrecht | |
Heal-Me Personalized Online Nutrition and Exercise Routines | NCT04666558 | Cancer Lung Diseases Liver Diseases | Exercise & Nutr... Exercise & Nutr... | 18 Years - | University of Alberta | |
TheraSphere With Durvalumab and Tremelimumab for HCC | NCT05063565 | Hepatocellular ... | TheraSphere Y-9... Durvalumab (Imf... Tremelimumab im... | 18 Years - | Boston Scientific Corporation | |
Everolimus in de Novo Liver Transplantation: a Multicentre Randomized Study | NCT01423708 | Liver Failure Liver Diseases Liver Cirrhosis Liver Neoplasms | Everolimus | 18 Years - 70 Years | Azienda Ospedaliera di Padova | |
Everolimus in de Novo Liver Transplantation: a Multicentre Randomized Study | NCT01423708 | Liver Failure Liver Diseases Liver Cirrhosis Liver Neoplasms | Everolimus | 18 Years - 70 Years | Azienda Ospedaliera di Padova | |
bTAE-HAIC Combined With System Therapy for Intermediate-advanced Huge HCC | NCT06061276 | Liver Diseases Hepatocellular ... Immunotherapy Camrelizumab Lenvatinib | bTAE-HAIC Lenvatinib Camrelizumab | 18 Years - 75 Years | Sun Yat-sen University | |
Mesenchymal Stem Cells After Renal or Liver Transplantation | NCT01429038 | Liver Failure Kidney Failure | Mesenchymal Ste... | 18 Years - 75 Years | University of Liege | |
Utilization of MAsS in Patients Undergoing LT for HCC | NCT05184283 | NAFLD Hepatocellular ... Liver Diseases Liver Cancer Cirrhosis, Live... Hepatitis C | 18 Years - 75 Years | Columbia University | ||
Extracellular RNA Markers of Liver Disease and Cancer | NCT02908048 | Hepatocellular ... Biliary Tract C... Cirrhosis Liver Diseases | Blood samples | 18 Years - | Mayo Clinic | |
Octreotide in Severe Polycystic Liver Disease | NCT00426153 | Polycystic Kidn... Polycystic Live... Hepatomegaly Liver Diseases Kidney, Polycys... Abdominal Pain | Octreotide Placebo | 18 Years - 80 Years | Mayo Clinic | |
Patient Reported Unmet Needs for Function and Supportive Occupational- and Physiotherapy Rehabilitation Interventions | NCT04066153 | Cancer Kidney Diseases Heart Failure Neurologic Diso... Liver Diseases Pulmonary Disea... Side Effect Quality of Life Physical Disord... | 18 Years - | Rigshospitalet, Denmark | ||
Heal-Me Personalized Online Nutrition and Exercise Routines | NCT04666558 | Cancer Lung Diseases Liver Diseases | Exercise & Nutr... Exercise & Nutr... | 18 Years - | University of Alberta | |
Early Detection of Hepatocellular Carcinoma in a High-risk Prospective Cohort (ELEGANCE) | NCT04965259 | Liver Diseases | 40 Years - 90 Years | National Cancer Centre, Singapore |